FDA Import Refusal BNI-0064336-9/251/1A — Patheon Inc.
The FDA refused shipment BNI-0064336-9/251/1A from Patheon Inc. (Canada) on April 20, 2018. The refused product falls under Drugs and Biologics — METHYLPREDNISOLONE (GLUCOCORTICOID). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 20, 2018
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 64LDY44 METHYLPREDNISOLONE (GLUCOCORTICOID)
- Charges
- 75